TriSalus Life Sciences, Inc.·4

May 15, 4:39 PM ET

Gordon Gary B. 4

4 · TriSalus Life Sciences, Inc. · Filed May 15, 2026

Research Summary

AI-generated summary of this filing

Updated

TriSalus (TLSI) Director Gary B. Gordon Receives Stock Awards

What Happened Director Gary B. Gordon received three awards from TriSalus Life Sciences (TLSI) on May 14, 2026: 28,201 restricted stock units (RSUs), 24,553 RSUs elected in lieu of cash retainer, and a derivative award covering 56,403 shares (an option). All grants were reported at $0.00 per share (awards/compensation), for a combined total of 109,157 underlying shares; there was no immediate cash payment.

Key Details

  • Transaction date: May 14, 2026; Form 4 filed May 15, 2026 (timely).
  • Transaction type: A = Award/Grant (RSUs and a derivative option), reported at $0.00.
  • Specific grants and vesting:
    • 28,201 RSUs (F1) — fully vest on May 14, 2027, subject to continued service.
    • 24,553 Retainer RSUs (F2) — elected in lieu of 2026 board cash retainer; vest quarterly in equal one‑third installments through the remainder of 2026, subject to continued service.
    • 56,403 derivative award (option) (F3) — vests in full on May 14, 2027, subject to continued service.
  • Shares owned after transaction: Not specified in the provided filing details.
  • Filing timeliness: Reported the next day (no late filing indicated).

Context These are compensation grants (RSUs and an option) rather than open‑market purchases or sales. RSUs convert into common shares upon vesting; the derivative award is an option-style grant that vests in one year. Such awards are routine director compensation and do not by themselves indicate buying or selling intent in the market.

Insider Transaction Report

Form 4
Period: 2026-05-14
Transactions
  • Award

    Common Stock

    [F1]
    2026-05-14+28,20137,957 total
  • Award

    Common Stock

    [F2]
    2026-05-14+24,55362,510 total
  • Award

    Director Stock Option (right to buy)

    [F3]
    2026-05-14+56,403112,653 total
    Exercise: $2.52Exp: 2036-05-13Common Stock (56,403 underlying)
Footnotes (3)
  • [F1]Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU award shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer.
  • [F2]Represents grant of restricted stock units (the "Retainer RSU Award") payable solely in common stock of the Issuer. The Reporting Person elected to receive the Retainer RSU Award in lieu of 2026 board service retainer cash fees provided for under the Issuer's Non-Employee Director Compensation Policy. The shares subject to the Retainer RSU Award shall vest quarterly in equal one-third installments through the remainder of 2026, subject to the Reporting Person's continued service with the Issuer.
  • [F3]The shares subject to the option shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer.
Signature
/s/ Mary Szela, Attorney-in-Fact|2026-05-15

Documents

1 file
  • 4
    wk-form4_1778877558.xmlPrimary

    FORM 4